Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Melanoma × Blood Specimen Collection × Clear all

Phase

Status

Completed 15 Unknown 7 Recruiting 7 Terminated 3 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 8 Neoplasms 7 Carcinoma, Non-Small-Cell Lung 4 Ovarian Neoplasms 3 Lung Neoplasms 3 Triple Negative Breast Neoplasms 2 Myelodysplastic Syndromes 2 Lung Diseases 2 Head and Neck Neoplasms 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Weight Loss 1 Sleep Apnea Syndromes 1 Sarcoma 1 Pyruvate Kinase Deficiency of Red Cells 1 Prostatic Neoplasms 1 Primary Ovarian Insufficiency 1 Pituitary Neoplasms 1 Pancreatic Neoplasms 1 Overweight 1 Obesity, Morbid 1 Obesity 1 Nervous System Diseases 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myasthenia Gravis 1 Muscle Weakness 1

Interventions

pembrolizumab 60 Nivolumab 38 Ipilimumab 25 trametinib 11 Specimen Handling 9 Cyclophosphamide 9 dabrafenib 8 Magnetic Resonance Spectroscopy 8 fludarabine 7 CTLA-4 Antigen 7 encorafenib 6 binimetinib 6 Radiosurgery 6 Interleukin-2 6 Biopsy 6 lenvatinib 5 fludarabine phosphate 5 atezolizumab 5 Radiotherapy 5 Introns 5 Cisplatin 5 durvalumab 4 dostarlimab 4 cobimetinib 4 Pemetrexed 4 Paclitaxel 4 Interferon alpha-2 4 Carboplatin 4 tocilizumab 3 tislelizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02068196 2023-03-24

Ipi4

Oslo University Hospital

Phase 4 Active not recruiting

Melanoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡